J Oyee

发表论文 79 篇 · 总被引 1301 次 · h-index 19

代表论文

• Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial (2022 · Clinical Infectious Diseases · 被引 174)
• A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer (2015 · Thorax · 被引 118)
• Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials (2018 · Open Forum Infectious Diseases · 被引 42)
• Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA ‐B*5701 Screening as a Risk‐Mitigation Measure (2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 被引 23)
• Eribulin for the Treatment of Advanced or Metastatic Breast Cancer: A NICE Single Technology Appraisal (2014 · PharmacoEconomics · 被引 17)
• Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196 (2024 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 8)